380 related articles for article (PubMed ID: 19340749)
1. [Cardiac amyloidosis--cardiovascular magnetic resonance imaging as a valuable diagnostic tool].
Braun G; Sechtem U; Mahrholdt H
Dtsch Med Wochenschr; 2009 Apr; 134(15):734-7. PubMed ID: 19340749
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, pattern, and functional impact of late gadolinium enhancement in left ventricular hypertrophy due to aortic valve stenosis.
Nassenstein K; Bruder O; Breuckmann F; Erbel R; Barkhausen J; Schlosser T
Rofo; 2009 May; 181(5):472-6. PubMed ID: 19241322
[TBL] [Abstract][Full Text] [Related]
3. Absolute assessment of aortic valve stenosis by planimetry using cardiovascular magnetic resonance imaging: comparison with transesophageal echocardiography, transthoracic echocardiography, and cardiac catheterisation.
Reant P; Lederlin M; Lafitte S; Serri K; Montaudon M; Corneloup O; Roudaut R; Laurent F
Eur J Radiol; 2006 Aug; 59(2):276-83. PubMed ID: 16873006
[TBL] [Abstract][Full Text] [Related]
4. Correlation of aortic valve area obtained by the velocity-encoded phase contrast continuity method to direct planimetry using cardiovascular magnetic resonance.
Tanaka K; Makaryus AN; Wolff SD
J Cardiovasc Magn Reson; 2007; 9(5):799-805. PubMed ID: 17891618
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of cardiovascular magnetic resonance to assess the orifice area of aortic bioprostheses.
von Knobelsdorff-Brenkenhoff F; Rudolph A; Wassmuth R; Bohl S; Buschmann EE; Abdel-Aty H; Dietz R; Schulz-Menger J
Circ Cardiovasc Imaging; 2009 Sep; 2(5):397-404, 2 p following 404. PubMed ID: 19808628
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.
Vogelsberg H; Mahrholdt H; Deluigi CC; Yilmaz A; Kispert EM; Greulich S; Klingel K; Kandolf R; Sechtem U
J Am Coll Cardiol; 2008 Mar; 51(10):1022-30. PubMed ID: 18325442
[TBL] [Abstract][Full Text] [Related]
7. [Use of cardiovascular magnetic resonance (CMR) in preoperative assessment of aortic stenosis--case report].
Pasowicz M; Klimeczek P; Wicher-Muniak E; Kolasa-Trela R; Podolec P; Tracz W; Sadowski J
Przegl Lek; 2004; 61(6):596-9. PubMed ID: 15724643
[TBL] [Abstract][Full Text] [Related]
8. Planimetry of the Orifice Area in Aortic Valve Stenosis Using Phase-Contrast Cardiac Magnetic Resonance Imaging.
Abe H; Iguchi N; Utanohara Y; Takada K; Hen Y; Machida H; Takeda N; Sumiyoshi T
Int Heart J; 2018 Jan; 59(1):77-80. PubMed ID: 29279525
[TBL] [Abstract][Full Text] [Related]
9. [Value of cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis].
Zhu KB; Cheng ZW; Tian Z; Zhao DC; Liu YT; Lin X; Chen TB; Xie HZ; Zeng Y; Fang LG; Jiang XC; Cui QC; Fang Q
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):915-9. PubMed ID: 22321275
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of myocardial T2 relaxation times in cardiac amyloidosis.
Sparrow P; Amirabadi A; Sussman MS; Paul N; Merchant N
J Magn Reson Imaging; 2009 Nov; 30(5):942-6. PubMed ID: 19780184
[TBL] [Abstract][Full Text] [Related]
11. Cardiac changes in systemic amyloidosis: visualisation by magnetic resonance imaging.
Cheng AS; Banning AP; Mitchell AR; Neubauer S; Selvanayagam JB
Int J Cardiol; 2006 Oct; 113(1):E21-3. PubMed ID: 17049635
[TBL] [Abstract][Full Text] [Related]
12. Clinical applications of cardiac magnetic resonance imaging.
Pilz G; Heer T; Harrer E; Ali E; Hoefling B
Minerva Cardioangiol; 2009 Jun; 57(3):299-313. PubMed ID: 19513011
[TBL] [Abstract][Full Text] [Related]
13. Cardiac magnetic resonance imaging findings are useful for differentiating between hypertrophic obstructive cardiomyopathy and aortic valve stenosis in elderly patients.
Amano Y; Takayama M; Kumita S
J Comput Assist Tomogr; 2009; 33(3):354-8. PubMed ID: 19478626
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of aortic stenosis by cardiovascular magnetic resonance imaging: comparison with established routine clinical techniques.
Kupfahl C; Honold M; Meinhardt G; Vogelsberg H; Wagner A; Mahrholdt H; Sechtem U
Heart; 2004 Aug; 90(8):893-901. PubMed ID: 15253962
[TBL] [Abstract][Full Text] [Related]
15. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.
Roe RH; Fisher Y; Eagle RC; Fine HF; Cunningham ET
Ophthalmology; 2007 Nov; 114(11):e33-7. PubMed ID: 17980738
[TBL] [Abstract][Full Text] [Related]
16. CMR-based differentiation of AL and ATTR cardiac amyloidosis.
Dungu JN; Valencia O; Pinney JH; Gibbs SD; Rowczenio D; Gilbertson JA; Lachmann HJ; Wechalekar A; Gillmore JD; Whelan CJ; Hawkins PN; Anderson LJ
JACC Cardiovasc Imaging; 2014 Feb; 7(2):133-42. PubMed ID: 24412186
[TBL] [Abstract][Full Text] [Related]
17. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study.
Banypersad SM; Sado DM; Flett AS; Gibbs SD; Pinney JH; Maestrini V; Cox AT; Fontana M; Whelan CJ; Wechalekar AD; Hawkins PN; Moon JC
Circ Cardiovasc Imaging; 2013 Jan; 6(1):34-9. PubMed ID: 23192846
[TBL] [Abstract][Full Text] [Related]
18. Cardiac amyloidosis: new insights into diagnosis and management.
Eshaghian S; Kaul S; Shah PK
Rev Cardiovasc Med; 2007; 8(4):189-99. PubMed ID: 18192942
[TBL] [Abstract][Full Text] [Related]
19. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.
Flett AS; Hayward MP; Ashworth MT; Hansen MS; Taylor AM; Elliott PM; McGregor C; Moon JC
Circulation; 2010 Jul; 122(2):138-44. PubMed ID: 20585010
[TBL] [Abstract][Full Text] [Related]
20. Value of cardiovascular magnetic resonance in suspected cardiac amyloidosis.
Fernandez AB; Leitner J; Okolo J; Atalay MK; Goldstein L; Abbott JD
J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):590-2. PubMed ID: 22306785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
